Hero image with Pittsburgh background https://pittplusme.org/study/1093

We're sorry. This study is closed and no longer recruiting participants.

STUDY BASICS

Have you been diagnosed with pancreatic cancer that has been staged as potentially resectable (able to be cut out)? If so, you may be eligible to participate in a study to see if the combination of chemotherapy drugs (drug regimen) will help kill cancer cells, making the tumor smaller. All participants will receive 2 cycles of chemotherapy followed by surgical removal of their tumor.


IRB: PRO17080599
- Randomized Phase II trial of Pre-Operative Gemcitabine, Nab-Paclitaxel, and hydroxychloroquine with or without Avelumab (PGHA vs. PGH)

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/1093 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe